Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer

This publication has 12 references indexed in Scilit:

• Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer
  British Journal of Cancer, 1996
• New endocrine therapies for breast cancer
  European Journal Of Cancer, 1996
• Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer
  The Lancet, 1995
• Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy
  European Journal of Cancer and Clinical Oncology, 1989
• Novel antioestrogens without partial agonist activity
  Journal of Steroid Biochemistry, 1988
• The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast
  European Journal of Cancer and Clinical Oncology, 1988
• STEROIDAL PURE ANTIOESTROGENS
  Journal of Endocrinology, 1987
• Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.
  BMJ, 1981
• Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland
  Cancer, 1977